Clinical Trials Browser

Interventional × Cutaneous Squamous Cell Carcinoma (CSCC) × 1 year × Clear all

NCT07100925 2025-08-03

A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

Phase 1 Not yet recruiting

DermatologicOther solid neoplasm

Cutaneous Squamous Cell Carcinoma (CSCC)